HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
FCE 23884
structure given in first source
Also Known As:
4-(9,10-didehydro-6-methylergolin-8-yl)methylpiperazine-2,6-dione; FCE-23884; 2,6-Piperazinedione, 4-(((8beta)-9,10-didehydro-6-methylergolin-8-yl)methyl)-
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Alkaloids: 5398
Ergot Alkaloids: 208
Ergolines: 109
FCE 23884: 2
Fused-Ring Heterocyclic Compounds
4 or More Rings Heterocyclic Compounds
Ergolines: 109
FCE 23884: 2
Related Diseases
1.
Hypokinesia (Bradykinesia)
10/01/1991 - "
FCE 23884 induces contralateral turning behavior in 6-hydroxydopamine-lesioned rats and reverses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced akinesia in monkeys and reserpine-induced hypokinesia in mice.
"
2.
Vomiting
10/01/1991 - "
In normal animals, FCE 23884 impairs Sidmans avoidance in rats, reduces spontaneous locomotion in mice and monkeys and antagonizes apomorphine-induced climbing behavior in mice, yawning in rats, emesis in dogs and amphetamine-induced toxicity in grouped mice.
"
3.
Parkinson Disease (Parkinson's Disease)
05/01/1996 - "
Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
"
Related Drugs and Biologics
1.
Reserpine (Serpasil)
2.
Dopamine (Intropin)
3.
Apomorphine
4.
Amphetamine (Amfetamine)